| __timestamp | Ligand Pharmaceuticals Incorporated | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12122000 | 15635076 |
| Thursday, January 1, 2015 | 13380000 | 23943601 |
| Friday, January 1, 2016 | 21221000 | 23689111 |
| Sunday, January 1, 2017 | 26887000 | 41006114 |
| Monday, January 1, 2018 | 27863000 | 51379106 |
| Tuesday, January 1, 2019 | 55908000 | 32705593 |
| Wednesday, January 1, 2020 | 59392000 | 53274000 |
| Friday, January 1, 2021 | 69012000 | 85352000 |
| Saturday, January 1, 2022 | 36082000 | 51999000 |
| Sunday, January 1, 2023 | 24537000 | 59471000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Summit Therapeutics Inc. and Ligand Pharmaceuticals Incorporated have demonstrated varying levels of investment in R&D, reflecting their strategic priorities. From 2014 to 2023, Summit Therapeutics consistently outpaced Ligand Pharmaceuticals in R&D spending, with an average annual expenditure that was approximately 27% higher. Notably, in 2021, Summit's R&D expenses peaked at 85 million, marking a 23% increase from the previous year, while Ligand's spending reached its highest in 2019. This trend underscores Summit's aggressive pursuit of innovation, particularly in recent years. As the pharmaceutical landscape continues to shift, these investments may well dictate the future trajectory of these companies, influencing their ability to bring groundbreaking therapies to market.
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Vertex Pharmaceuticals Incorporated vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Insmed Incorporated and Ligand Pharmaceuticals Incorporated
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated vs Xencor, Inc.: Strategic Focus on R&D Spending